DiaSorin Patents – Insights & Stats

DiaSorin has a total of 6999 patents globally, out of which 3695 have been granted. Of these 6999 patents, more than 46% patents are active. The USA is where DiaSorin has filed the maximum number of patents, followed by European Countries and China, it has generated an annual revenue of $1.46 billion in the year 2021. Parallelly, the USA seems to be the main focused R&D centre of DiaSorin.

DiaSorin was founded in the year 2000. The firm is an Italian multinational biotechnology company. As of October 2022, DiaSorin has a market cap of $6.39 Billion.

Do read about some of the most popular patents of DiaSorin which have been covered by us in this article and also you can find DiaSorin patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over DiaSorin patent portfolio.

How many patents does the CEO of DiaSorin have?

The CEO, Carlo Rosa, has 0 patents.

How many patents does DiaSorin have?

DiaSorin has a total of 6999 patents globally. These patents belong to 1863 unique patent families. Out of 6999 patents, 3274 patents are active.

How Many Patents did DiaSorin File Every Year?

DiaSorin Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantDiaSorin Applications FiledDiaSorin Patents Granted
2011341131
2012311189
2013223242
2014214224
2015275215
2016174188
2017149188
2018148192
2019130212
2020131214
202163169
20221486

How many DiaSorin patents are Alive/Dead?

DiaSorin Patent Portfolio

How Many Patents did DiaSorin File in Different Countries?

DiaSorin Worldwide Patent Filing

Countries in which DiaSorin Filed Patents

CountryPatents
United States Of America1364
Europe765
China415
Japan376
India339
Singapore328
Canada328
Spain289
Australia284
Korea (South)240
Germany200
Austria124
Brazil116
Denmark93
Poland90
Hong Kong (S.A.R.)81
Mexico79
South Africa77
Taiwan71
Portugal68
Slovenia62
Argentina52
New Zealand50
Serbia46
Norway45
Croatia44
Israel36
Hungary35
Costa Rica34
Iceland33
Eurasia29
Czech Republic27
Slovakia24
Ecuador18
Dominican Republic18
Viet Nam16
Turkey14
United Kingdom13
Colombia12
Peru12
Ukraine11
Bulgaria11
Italy9
Estonia8
Chile8
Malaysia7
Thailand7
Cyprus7
Morocco6
Yugoslavia/Serbia and Montenegro6
Finland5
Netherlands2
Tunisia2
Georgia2
Russia2
France2
Saudi Arabia1
El Salvador1
Honduras1
Cuba1
Montenegro1
Belarus1
Latvia1
Luxembourg1

Where are Research Centres of DiaSorin Patents Located?

R&D Centres of DiaSorin

10 Best DiaSorin Patents

US6592822B1 is the most popular patent in the DiaSorin portfolio. It has received 646 citations so far from companies like Fuji Photo Film, Hitachi Software Engineering, and P&G.

Below is the list of 10 most cited patents of DiaSorin:

Publication NumberCitation Count
US6592822B1426
US6734401B2322
US6449562B1314
US6506564B1307
US20060078998A1229
US6750016B2218
US6514295B1218
US6417340B1209
US6767702B2200
US6528165B2199

What are DiaSorins key innovation segments?

What Technologies are Covered by DiaSorin?

The chart below distributes patents filed by DiaSorin in different countries on the basis of the technology protected in patents. It also represents the markets where DiaSorin thinks it’s important to protect particular technology inventions.

R&D Focus: How has DiaSorin‘s search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by DiaSorin?

Related Articles

5ire Patents – Insights & Stats (Updated 2024)

5ire has a total of 7 patents globally, out of which no patent has been granted. Of these 7 patents, more than 14% patents are active. The United States of America and United Kingdom is where 5ire has filed the maximum number of patents, followed by Europe (EPO). Parallelly, United

Read More »

Abogen Patents – Insights & Stats (Updated 2024)

Abogen has a total of 25 patents globally, out of which 10 have been granted. Of these 25 patents, more than 48% patents are active. Japan is where Abogen has filed the maximum number of patents, followed by Europe (EPO). Parallelly, Europe (EPO) seems to be the main focused R&D

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.